Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04523961 · ClinicalTrials.gov registry record · Phase 2
Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT04523961: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT04523961 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04523961, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of lidocaine 2.5%/prilocaine 2.5% cream versus lidocaine 23%/tetracaine 7% ointment for topical anesthesia prior to a nonablative laser procedure.
Interventions
- DRUG 2.5 g of lidocaine 23% / tetracaine 7% ointment without occlusion
- DRUG 7.5 g lidocaine 2.5%/ prilocaine 2.5% cream with occlusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2021-01-08 |
| Est. Completion | 2025-02-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04523961
The ClinicalTrials.gov registry entry for NCT04523961 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 2.5 g of lidocaine 23% / tetracaine 7% ointment without occlusion is the first listed.
NCT04523961 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04523961 about?
NCT04523961 is a clinical study titled "Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face". The purpose of this study is to determine the efficacy of lidocaine 2.5%/prilocaine 2.5% cream versus lidocaine 23%/tetracaine 7% ointment for topical anesthesia prior to a nonablative laser procedure.
What is the current status of trial NCT04523961?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2021-01-08. Estimated completion is 2025-02-19.
What interventions are being tested in trial NCT04523961?
The interventions under investigation include: 2.5 g of lidocaine 23% / tetracaine 7% ointment without occlusion (DRUG), 7.5 g lidocaine 2.5%/ prilocaine 2.5% cream with occlusion (DRUG).
Who is sponsoring clinical trial NCT04523961?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.